Immunome Research

Immunome Research
Open Access

ISSN: 1745-7580


Kasper Lamberth

Kasper Lamberth

Laboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

Kasper Lamberth, Ph.D., has very recently transitioned to the role as Department Head for Immunogenicity Prediction and Tolerance at Biopharmaceutical Research Unit, Novo Nordisk A/S. Dr. Lamberth joined Novo Nordisk 5 years ago and during this time he has worked with development of immunogenicity prediction tools as well as high throughput screening technologies. Prior to Novo Nordisk A/S, Dr. Lamberth worked for eight years with predictive immunogenicity tools, especially with MHC polymorphism and the identification of T-cell epitopes within the field of infectious diseases at Copenhagen University. Dr. Lamberth holds a MS in Biochemistry and a PhD in Immunology, both from Copenhagen University.
Research Interest

 Chemical Biology of Molecules,Class II MHC molecule

Relevant Topics